Public company
enGene Therapeutics Inc.
ENGNCIK 0001980845
Price$2.41
1 year-72.2%
Disclosed transactions1
Buys / sells0 / 0
Max Insider Score9
Connections with evidence2
ENGN · disclosed activity on price
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Duncan JasonChief Legal & Admin Officer | ENGNenGene Therapeutics Inc. Grant or award | A | — 500.0K sh | Nov 13, 2026 |
Verified connections
- In industryevidencePharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 13, 2026
- ← Insider ofevidenceDuncan JasonChief Legal & Admin Officer · Nov 13, 2026